Trials / Completed
CompletedNCT05080933
ECMO for COVID-19 vs Influenza A H1N1 Associated ARDS
Extracorporeal Membrane Oxygenation for COVID-19 and Influenza H1N1 Associated Acute Respiratory Distress Syndrome: a Multi-centre Retrospective Cohort Study
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 308 (actual)
- Sponsor
- University of Turin, Italy · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- —
Summary
Objective: Veno-venous ECMO has been used as a rescue therapy for patients with severe ARDS associated to influenza A H1N1 and COVID19 viral pneumonia. Little is known about outcome of these patients who required extracorporeal support. Research question: To compare outcome of patients who required VV ECMO for Covid19 and H1N1 associated ARDS
Conditions
Timeline
- Start date
- 2009-08-22
- Primary completion
- 2021-02-28
- Completion
- 2021-02-28
- First posted
- 2021-10-18
- Last updated
- 2021-10-18
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT05080933. Inclusion in this directory is not an endorsement.